VESSONE

This brand name is authorized in Ecuador

Active ingredients

The drug VESSONE contains one active pharmaceutical ingredient (API):

1 Vilazodone
UNII U8HTX2GK8J - VILAZODONE HYDROCHLORIDE

Vilazodone is a selective serotonin reuptake inhibitor and a 5HT1A receptor partial agonist. It is used for the treatment of major depressive disorder (MDD) in adults. The mechanism of action of vilazodone in the treatment of major depressive disorder is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS through selective inhibition of serotonin reuptake.

Read about Vilazodone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N06AX24 Vilazodone N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 5853-MEE-0121, 5854-MEE-0121, 5897-MEE-0121

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈